Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia
R. W. Schrier
and Others
- 16 Nov, 2006
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10
